Crossmark

Integration of CRISPR/Cas9 with multi-omics technologies to engineer secondary metabolite productions in medicinal plant: Challenges and Prospects

Published Online: 2024-11-04

Published Print: 2024-12

Authors

Borah, Anupriya

Singh, Shailey

Chattopadhyay, Rituja

Kaur, Jaspreet

Bari, Vinay Kumar https://orcid.org/0000-0002-5670-3798
License Information

Text and Data Mining valid from 2024-11-04

Version of Record valid from 2024-11-04
More Information

Article History

Received: 23 September 2024

Revised: 18 October 2024

Accepted: 22 October 2024

First Online: 4 November 2024

Declarations

:

: This article does not contain any studies with human participants or animals by any authors.

: Written informed consent was obtained from all the authors<b>.</b>

: The authors declare no competing interests.

Document is current